本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aclaris Therapeutics

3.62
+0.02000.56%
成交量:83.17万
成交额:298.00万
市值:5.33亿
市盈率:-6.18
高:3.65
开:3.65
低:3.51
收:3.60
52周最高:6.60
52周最低:1.74
股本:1.47亿
流通股本:1.01亿
量比:0.45
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
净资产收益率:-59.10%
总资产收益率:-28.98%
市净率:4.28
市盈率(LYR):-6.83

数据加载中...

2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/08

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/03

重要事件披露

Current report, items 7.01 and 9.01
2019/11/21

重要事件披露

Current report, items 7.01 and 9.01
2019/11/21

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

重要事件披露

Current report, items 1.01 and 9.01
2019/10/15

超过5%披露

General statement of acquisition of beneficial ownership
2019/10/11

重要事件披露

Current report, items 1.01, 1.02, 2.01, 7.01, and 9.01
2019/09/27

重要事件披露

Current report, items 7.01 and 9.01
2019/09/09

重要事件披露

Current report, item 5.02